Baltimore's Osiris Therapeutics' Stem Cell Drug Granted Orphan Drug Status by Fda

Extract


Baltimore's Osiris Therapeutics' Stem Cell Drug Granted Orphan Drug Status by Fda

Baltimore's Osiris Therapeutics Inc. has been granted orphan drug status by federal regulators for its lead stem cell drug candidate, Prochymal.The designation gives Osiris...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company